Preclinical Testing
The Preclinical Testing will involve assessment of novel drug molecules including genetic, peptide, and antibody-based therapies in cell-based and animal disease models. Expertise in cardiovascular disease, cancer, neuroscience, and infectious diseases will provide advice and assistance with evaluating novel drugs and therapeutic approaches.
Evaluating two novel small molecules in kidney and cardiovascular diseases
Evaluating novel small molecules in inflammatory disease
Based on preclinical data in cancer disease models we are providing advice and assistance with going forward with repositioning a drug for clinical trials